Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03358264 |
Date of registration:
|
26/11/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effect of L-Citrulline Supplementation on Arginase Activity and Vascular Function in Diabetes
|
Scientific title:
|
Effect of L-Citrulline Supplementation on Arginase Activity and Vascular Function in Type II Diabetes Mellitus |
Date of first enrolment:
|
January 1, 2017 |
Target sample size:
|
50 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03358264 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Jordan
| | | | | | | |
Contacts
|
Name:
|
Alia Shatanawi, PhD, DDS |
Address:
|
|
Telephone:
|
+96265355000 |
Email:
|
a.shatanawi@ju.edu.jo |
Affiliation:
|
|
|
Name:
|
Alia Shatanawi, PhD, DDS |
Address:
|
|
Telephone:
|
+96265355000 |
Email:
|
a.shatanawi@ju.edu.jo |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Type 2 diabetes Diabetic state: HbA1c>6
Exclusion Criteria:
Age minimum:
45 Years
Age maximum:
70 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Type 2 Diabetes Mellitus
|
Intervention(s)
|
Dietary Supplement: L-citrulline
|
Primary Outcome(s)
|
arginase activity
[Time Frame: 1 month]
|
Vascular function
[Time Frame: 1 month]
|
Secondary ID(s)
|
Pharmacology-Medicine-UJ
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|